SCHEMBL5316306

SCHEMBL5316306

OCc1nn(Cc2ccc(Cl)cc2F)c2cc(OC(F)(F)F)ccc12

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
F2RL3 Q96RI0 9/20 0.42
NR1H2 P55055 1/20 0.41
NR1H3 Q13133 1/20 0.41
RORC P51449 1/20 0.39
GRM2 Q14416 1/20 0.38
CYP2C9 P11712 4/20 0.37
CYP2D6 P10635 2/20 0.37
AKR1B1 P15121 1/20 0.37
CYP1A2 P05177 2/20 0.37
CYP3A4 P08684 2/20 0.37
ALOX5AP P20292 2/20 0.36
PPARG P37231 2/20 0.35
PPARA Q07869 2/20 0.35
EGFR P00533 1/20 0.35
CHRM4 P08173 1/20 0.35
ADRB1 P08588 1/20 0.35
ADRA2A P08913 1/20 0.35
ALOX5 P09917 1/20 0.35
ADRB3 P13945 1/20 0.35
DRD2 P14416 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5267634 0.92 NR1H2 (0.40) F2RL3NR1H2NR1H3RORCGRM2
SCHEMBL5320785 0.91 F2RL3 (0.43) F2RL3CYP2C9CYP2D6CYP1A2CYP3A4
SCHEMBL5272346 0.90 NR1H2 (0.39) F2RL3NR1H2NR1H3RORCGRM2
SCHEMBL5317487 0.89 F2RL3 (0.52) F2RL3RORCCYP2C9CYP2D6AKR1B1
SCHEMBL5373644 0.89 NR1H2 (0.38) F2RL3NR1H2NR1H3RORCGRM2
SCHEMBL5273572 0.89 F2RL3 (0.40) F2RL3CYP2C9CYP2D6CYP1A2CYP3A4
SCHEMBL5383568 0.88 NR1H2 (0.38) F2RL3NR1H2NR1H3RORCGRM2
SCHEMBL5319989 0.88 AKR1B1 (0.52) RORCCYP2C9AKR1B1CYP1A2PTGDR2
SCHEMBL5316549 0.86 SLC22A12 (0.42) RORCCYP2C9AKR1B1ALOX5APPPARG
SCHEMBL5323485 0.86 FFAR4 (0.42) RORCCYP2C9AKR1B1PPARGPPARA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1786424-A2 LONIDAMINE ANALOGUES AND THEIR USE IN MALE CONTRACEPTION AND CANCER TREATMENT The University of Kansas (US) 2007-05-23 EP claimed
WO-2006023704-A2 LONIDAMINE ANALOGUES AND THEIR USE IN MALE CONTRACEPTION AND CANCER TREATMENT UNIVERSITY OF KANSAS (US) 2006-03-02 WO claimed